The HealthTech Activator (HTA) maintains this collection of webinars and event recordings that are of interest to those in the healthtech sector. This page includes event recordings and third party webinar content only, for upcoming events please see the Events page.
Want to know more about the new US cybersecurity regulations for medical devices? Join the Johner Institute New Zealand to explore the FDA's new rules and their implications. Medical device consultant, startup founder, and regulatory expert Tyler Harmon presented the session. Watch this recording to learn more about the new requirements that set a firm baseline for companies during their device applications.
Event recording from June 2023. Join the HealthTech Activator for an overview of the ins and outs of FDA engagement, including a deep dive into what happens when engagement goes wrong, and a discussion on significant FDA initiatives for medical devices.
Event recording from June 2023. Join the HealthTech Activator for an overview of the US medical device reimbursement landscape, including components of US reimbursement, reimbursement strategy, impacts of pursuing the wrong pathway, and debunking common myths.
Engaging with relevant clinicians can ensure that a product addresses a common pain point, is effective, and meets the needs of the end user. Join Te Tītoki Mataora for a panel discussion focused on helping MedTech developers navigate the clinical engagement process for clinical input and validation.
Event recording from December 9 2022. Join the HealthTech Activator for an overview of some of the approaches used by decision makers in key markets when deciding on the value of a novel health technology, and some of the key trends that healthtech companies should be aware of.
Event recording from June 14 2022. Join the HTA for an overview of the European medical device regulatory landscape, including QMS requirements, authorised representation, health economics, and trends in EU regulations.
Event recording from November 9 2021. Join the HTA for a discussion on the US reimbursement landscape, including performing a reimbursement assessment, strategy, and key challenges relevant to medical device companies looking to the US.
Event recording from 4 November 2021. Join the HTA for a discussion on the importance of regulatory intelligence for healthtech companies, including finding regulatory information and managing, assessing, and reporting on the potential impact of regulatory changes.
Join the MedTech Innovator, Asia Pacific series for a discussion on the various reimbursement and health economic frameworks across the US and in Asia Pacific. Visit www.medtechinnovator.org to learn more.
Join the MedTech Innovator, Asia Pacific series for a discussion with regulatory affairs professionals Mary McNamara-Culliane, US-based, and Jack Wong, APAC-based. Visit www.medtechinnovator.org to learn more.
Join the MedTech Innovator, Asia Pacific series for a discussion with Stephen Lee, Director New Ventures at Johnson & Johnson, and Florian Belohlavek, Head of Strategy APAC at Siemens Healthineers. Visit www.medtechinnovator.org to learn more.
Join the MedTech Innovator, Asia Pacific series for a discussion with Singapore-based venture funding partners, Mark Wang and Joseph Mocanu, and Azran Osman-Rani, CEO & co-founder of Naluri. Visit www.medtechinnovator.org to learn more.
Using examples form the MedTech sector, Ross Pearce of Callaghan Innovation discusses the 10 types of innovation, along with how businesses can integrate these innovation activities to optimise the value that can be captured from their products.
In this webinar, Luis Jimenez of Brandwood CKC discusses the key considerations for registering innovative products and changes to existing products incorporating innovative modifications. Visit https://www.pharmalex.com for more.
The HealthTech Activator (HTA) maintains a collection of third party webinars of interest to those in the healthtech sector on this page. The third party webinars do not reflect the opinion of the HTA or Callaghan Innovation and neither the HTA nor Callaghan Innovation endorse the webinars, their content or their authors.
